Acella Pharmaceuticals is recalling approximately 29,112 bottles of NP Thyroid (levothyroxine/liothyronine) tablets because they are subpotent. Testing found that these tablets contain less than the required amount of levothyroxine (T4), which is the active hormone intended to treat thyroid conditions. The recall affects 100-count bottles of both NP Thyroid 15 and NP Thyroid 120 that were distributed nationwide. If you have this medication, you should consult your healthcare provider or pharmacist before you stop taking it, as an untreated underactive thyroid can lead to serious health complications.
Because these tablets contain less active medication than labeled, patients may not receive enough thyroid hormone. This can lead to symptoms of hypothyroidism, such as extreme fatigue, weight gain, hair loss, depression, and increased sensitivity to cold.
Healthcare provider consultation and pharmacy refund
15 mg tablet picture
120 mg tablet picture
NPThyroid15, Thyroid Tablets, USP, ¼ grain (15 mg), 100 tablets, front label
NPThyroid120, Thyroid Tablets, USP, 2 grain (120 mg), 100 tablets, front label
If you or a family member were harmed by this recalled product, you may have legal rights. Consider consulting a consumer protection attorney to understand your options for compensation.
This is general information, not legal advice. Go Backs is not a law firm and does not provide legal services.
AI-Enhanced Content: The summary, action steps, and risk assessment on this page were generated by AI from official government recall data to improve readability. This is not legal or medical advice. Always refer to the official agency sources below for authoritative information.
Sources: FDA iRES · FDA Press Release · Raw API Response
openFDA Disclaimer: This recall information is sourced from the openFDA API. Do not rely on openFDA to make decisions regarding medical care. While we make every effort to ensure that data is accurate, you should assume all results are unvalidated. Refer to the openFDA terms of service for more information.